Kane Biotech Inc

Research Kane Biotech Inc (KNE) on Bullrun: market cap CAD 6.15M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKNE
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCAD
• Market capCAD 6.15M
• Financial periodQ3 2025
• RevenueCAD 8.50K
• Net income-CAD 607.35K
• Free cash flow-CAD 703.83K
• Gross margin-60.3%

Valuation Snapshot

latest market cap is CAD 6.15M.

About Kane Biotech Inc

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic infections.

Frequently asked questions

What is Kane Biotech Inc's market cap?

Kane Biotech Inc's market capitalization is CAD 6.15M.

What does Kane Biotech Inc do?

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.